Europe Establishes First Core Competency Framework for Psychiatric Pharmacy

Europe Establishes First Core Competency Framework for Psychiatric Pharmacy

The historical absence of an internationally recognized framework defining the specific roles of psychiatric pharmacists has long hindered the professionalization of mental healthcare in Europe. This fundamental gap often left clinicians, educators, and administrators navigating a fragmented landscape where the definition of “specialized care” varied significantly from one border to the next. The recent publication of a comprehensive study in the International Journal of Clinical Pharmacy represents a decisive turning point in this narrative, establishing the first pan-European core competency framework specifically for psychiatric pharmacy. By defining forty distinct competencies across seven professional domains, the research provides a much-needed blueprint for harmonizing workforce development and educational curricula across diverse healthcare jurisdictions. This initiative, spearheaded by the European Society of Clinical Pharmacy (ESCP) Mental Health Special Interest Group, addresses the systemic inconsistencies that have historically limited the impact of pharmaceutical care in mental health settings. As healthcare systems throughout the continent face rising demands for psychiatric services, the establishment of these clear, observable standards ensures that pharmacists can operate at the highest level of their clinical training, providing a consistent safety net for a particularly vulnerable population of patients.

The Methodological Foundations of e-Delphi Consensus

To ensure that the newly established framework was both rigorous and universally applicable, the research team utilized a modified two-round electronic Delphi (e-Delphi) consensus method. This structured communication technique is designed to extract reliable insights from a diverse panel of experts by filtering through individual biases and focusing on shared professional priorities. The process began with the European Society of Clinical Pharmacy Mental Health Special Interest Group drafting a preliminary list of competencies. This initial phase drew significant inspiration from established global benchmarks, including the International Pharmaceutical Federation (FIP) Mental Health Care Handbook and the Advanced Pharmacist Mental Health Curriculum from the United Kingdom. By building upon these existing high-quality sources, the researchers ensured the framework was grounded in evidence-based practice while remaining flexible enough to accommodate the various legal and structural realities of different European nations. This preliminary work resulted in a list of potential criteria that were then subjected to intense scrutiny by a carefully selected panel of specialists representing the cutting edge of psychiatric pharmacy.

The selection of the expert panel was critical to the study’s overall validity and pan-European relevance. Thirty-nine qualified specialists from thirteen different European countries were recruited to participate in the consensus rounds conducted during the first half of 2026. To qualify, participants were required to be registered clinical pharmacists with at least three years of dedicated experience in a psychiatric hospital setting. This diverse geographic and professional mix ensured that the resulting framework was not merely a reflection of one nation’s healthcare model but rather a robust consensus applicable to various systems, ranging from the highly integrated pharmacy services in Slovenia to emerging clinical models in Central Europe. Throughout the two rounds of the Delphi process, experts evaluated each competency using a strict statistical threshold, requiring at least an 80% agreement rate for a criterion to be included. This rigorous approach guaranteed that the final forty competencies represented a stable, high-level agreement among the continent’s leading specialists, providing a firm foundation for future professional standardization and the eventual credentialing of psychiatric pharmacists.

Clinical Domains and Medication Optimization Strategies

The framework organizes the complex duties of a psychiatric pharmacist into seven distinct professional domains, with medication optimization emerging as one of the most critical areas of focus. This domain received some of the highest consensus scores, reflecting a universal agreement that pharmacists must serve as the primary guardians of medication safety. In the psychiatric field, patients often present with complex clinical pictures involving multiple comorbidities, necessitating high-risk psychotropic regimens that are prone to drug-drug interactions and adverse effects. The framework codifies the pharmacist’s role in conducting comprehensive medication reviews and reconciliation, ensuring that therapeutic interventions are both safe and effective. By establishing these clinical baselines, the framework empowers pharmacists to intervene proactively in the prescribing process, moving beyond simple dispensing to a role of clinical oversight. This evolution is vital in psychiatric care, where the subtle nuances of dosage adjustments and the management of long-term side effects can determine the success or failure of a patient’s recovery journey.

Beyond the technical aspects of medication management, the framework highlights the importance of navigating complex therapeutic regimens through a multidisciplinary lens. Experts agreed that the psychiatric pharmacist’s ability to manage drug interactions is not just a technical skill but a clinical necessity that prevents avoidable hospitalizations. The consensus reached in this domain suggests that regardless of local legislation or hospital size, the core value of the psychiatric pharmacist lies in their ability to provide expert oversight of psychotropic therapy. This standardization helps healthcare administrators understand the specific value of having a specialist on the unit, rather than a generalist who may not be familiar with the intricate pharmacokinetic profiles of modern antipsychotics or mood stabilizers. By providing a clear definition of medication optimization, the framework establishes a benchmark for clinical excellence that can be measured and audited, ensuring that patients across Europe receive a high standard of pharmaceutical care regardless of their location.

Integrating Physical Health and Person-Centered Care

A significant component of the new competency framework addresses the “mortality gap,” a well-documented phenomenon where individuals with severe mental illness face a significantly reduced life expectancy compared to the general population. This gap is largely driven by preventable cardiometabolic diseases, often exacerbated by the side effects of psychotropic medications. The framework explicitly codifies the psychiatric pharmacist’s responsibility in monitoring physical health parameters and implementing lifestyle interventions. By identifying risks such as weight gain, dyslipidemia, and glucose intolerance early in the treatment process, pharmacists can play a direct role in reducing the long-term physical health burden of psychiatric patients. While the consensus on specific lifestyle interventions was slightly lower than that for risk identification, the inclusion of these competencies marks a shift toward a more holistic view of the pharmacist’s role. They are no longer just medication experts but are increasingly seen as integral members of the team responsible for the patient’s overall physical well-being.

Parallel to physical health monitoring is the emphasis on person-centered care and the promotion of shared clinical decision-making. The framework reached a total consensus regarding the pharmacist’s role in educating patients about their treatments and addressing their specific concerns. This domain recognizes that recovery in mental health is a deeply personal process that requires the patient to be an active participant in their own care. Pharmacists are expected to use their expertise to bridge the communication gap between the clinical team and the patient, ensuring that treatment plans align with the individual’s goals and preferences. By emphasizing counseling and advocacy, the framework moves the profession away from a paternalistic model of care toward a collaborative approach. This transition is essential for improving medication adherence and fostering a therapeutic alliance, which are critical factors in the successful management of chronic mental health conditions. This focus on the human element ensures that the technical expertise of the pharmacist is applied in a way that respects the dignity and autonomy of the patient.

Strengthening Interprofessional Collaboration and Coordination

Modern psychiatric care is inherently a team effort, and the new framework reinforces the necessity of integrating pharmacists into multidisciplinary environments. The domain of interprofessional collaboration achieved strong consensus across all five of its criteria, highlighting the pharmacist’s role as a vital link in the chain of care. This involves not only working closely with psychiatrists and nurses on the unit but also coordinating transitions between different care settings, such as the move from inpatient hospitalization to community-based primary care. Standardizing the exchange of care plans and ensuring that medication changes are communicated clearly to all stakeholders prevents the common “revolving door” phenomenon where patients relapse due to poor coordination. By formalizing these collaborative roles, the framework provides a template for how pharmacists should interact with other healthcare professionals to streamline the patient journey and minimize clinical errors during high-risk transition periods.

In addition to direct patient-facing collaboration, the framework establishes clear responsibilities for administrative and governance activities. This includes the development of local clinical guidelines, the evaluation of hospital formularies, and the management of robust adverse event reporting systems. These “behind-the-scenes” functions are essential for ensuring that the entire healthcare facility operates within a safe and evidence-based environment. The consensus reached in this domain suggests that a specialist psychiatric pharmacist is responsible for the overall quality and safety of the medication-use process within their institution. By conducting clinical audits and overseeing pharmacy-led governance initiatives, specialists ensure that the latest research findings are translated into daily practice. This systematic approach to quality improvement helps healthcare organizations maintain high standards of care while also managing the rising costs of specialized mental health treatments. The pharmacist’s role in governance thus provides a bridge between individual patient care and the broader institutional goals of safety, efficiency, and fiscal responsibility.

Navigating Research Obligations and the Prescribing Paradox

The framework positions psychiatric pharmacy as an academic and investigative discipline by including a dedicated domain for research, education, and service development. There was unanimous agreement among the expert panel that specialists should contribute to the body of clinical evidence and take an active role in training the next generation of healthcare providers. This commitment to continuous learning and knowledge dissemination ensures that the profession remains dynamic and responsive to new therapeutic breakthroughs. Pharmacists are encouraged to lead service development projects that improve patient outcomes and to engage in research that addresses the unique challenges of mental healthcare. By embedding these academic responsibilities into the core competency framework, the ESCP Mental Health SIG has sent a clear message that clinical pharmacy is not just a service-delivery role but a scholarly pursuit that requires ongoing engagement with the latest scientific literature and methodological advancements.

Despite the broad agreement on most aspects of the pharmacist’s role, the study highlighted a significant “prescribing paradox” that reflects the current legal limitations of the profession in Europe. While independent pharmacist prescribing is highly successful in countries like the United Kingdom and Slovenia, it failed to reach the 80% consensus threshold required for inclusion as a core European competency. This exclusion was not due to a lack of perceived value, but rather a reflection of the profound structural and legislative disparities that exist across the continent. In many European jurisdictions, prescribing remains the exclusive legal prerogative of physicians, making it impossible to define it as a “core” competency for every specialist on the continent. This finding underscores the fact that while the framework provides a unified vision for the profession, the actual scope of practice is still heavily influenced by national laws. Nevertheless, the framework provides a solid foundation from which pharmacists can advocate for expanded roles and legislative changes that allow them to practice at the full extent of their clinical capabilities.

Bridging the Gap Between Standards and Practice

One of the most pressing themes emerging from the study is the “implementation gap,” which describes the disconnect between what experts agree should happen and what is actually possible in daily hospital practice. While there is a high level of consensus on the importance of research and service development, the reality for many psychiatric pharmacists is a lack of protected time and dedicated funding. Many practitioners are so overwhelmed by immediate clinical and dispensing duties that the higher-level competencies, such as leading clinical audits or engaging in academic research, often remain aspirational. The framework identifies these structural barriers as significant hurdles to the full professionalization of the field. To overcome this, healthcare systems must invest in the necessary infrastructure, including specialized postgraduate training programs and administrative support, to allow pharmacists to fulfill the roles defined in the forty core competencies. Without this institutional backing, the framework risks remaining a theoretical document rather than a catalyst for real-world change.

Addressing the implementation gap requires a strategic approach to workforce planning and education. The framework serves as a guide for universities and professional bodies to design curricula that specifically target the identified competencies, ensuring that new graduates enter the workforce with the skills needed to excel in psychiatric settings. Furthermore, by providing a standardized benchmark, the framework allows healthcare managers to justify the need for more specialized pharmacy positions and the resources required to support them. The transition from generalist to specialist care is a complex process that involves shifting professional identities and renegotiating roles within the healthcare team. By clearly defining what a specialist psychiatric pharmacist does, the framework provides the clarity needed to navigate these shifts. Ultimately, the goal is to move toward a model where the high-level expertise described by the consensus panel becomes the standard expectation for every mental health facility in Europe, ensuring that patient safety and therapeutic efficacy are never compromised by a lack of specialized oversight.

Transforming Patient Care Through Standardized Competency

The establishment of the first core competency framework for psychiatric pharmacy in Europe represented a monumental step toward a more professionalized and safe mental healthcare system. By distilling the expertise of specialists from thirteen countries into forty observable activities, the ESCP Mental Health SIG successfully created a tool that transcends national boundaries and provides a unified vision for the future of the profession. This project successfully moved the conversation away from vague descriptions of “pharmaceutical care” toward concrete, measurable standards that can be used for training, recruitment, and clinical auditing. The rigorous e-Delphi process ensured that these standards were not just theoretical ideals but were grounded in the practical realities of hospital-based practice. While the framework is intentionally aspirational, it provides the necessary roadmap for those seeking to elevate the standard of pharmacy services in their respective regions, providing a clear path for professional development and a powerful tool for advocacy.

Moving forward, the primary focus must shift toward the widespread adoption and local adaptation of these competencies. Healthcare administrators and policymakers were encouraged to use this framework as a benchmark for evaluating their current services and identifying areas where additional investment is needed. The inclusion of physical health monitoring and person-centered care highlights a shift toward a more holistic patient journey, where the pharmacist is recognized as a key ally in the recovery process. This initiative did not just define a job description; it established a new expectation for excellence across the European continent. By ensuring that psychiatric pharmacists possess a standardized set of high-level skills, the healthcare system is better equipped to manage the complex needs of patients with mental health conditions. The long-term impact of this framework will be measured by its ability to reduce the mortality gap, minimize medication errors, and ensure that every patient in a European psychiatric facility has access to the highest standard of pharmaceutical expertise.

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later